The Center for Cancer Research, Tsinghua University, aims to globally align with national strategic needs, cutting-edge technology, and original innovation, focusing on key areas such as cancer prevention and treatment, drug development, and transformation. The center promotes the integration of basic research, applied research, and industrialization, effectively enhancing key core technologies and independent innovation capabilities.

The center (under preparation) will focus on major issues related to common and frequent cancers in China, including prevention, occurrence, metastasis, and drug resistance. It will carry out frontier scientific research in three main areas: basic cancer research, molecular cancer diagnostics, and precision cancer prevention and treatment.

Biomedical disciplines are at a strategic critical period and an important opportunity for deep integration of basic and clinical innovation. The cancer research discipline will fully leverage its "leading" role and collaborate with the School of Medicine to build a high-level strategic cooperation platform. This collaboration will drive high-level scientific research development, enabling breakthroughs and new advancements. The center will be oriented towards international academic frontiers, relying on Tsinghua University’s Cancer Research Center to further improve an integrated platform for basic and translational medicine. This includes supporting systems such as cancer samples and big data, medicinal chemistry, model animals, organoids, metabolomics, molecular imaging, gene editing, cancer biomarkers and liquid biopsy, cancer immunology and vaccines, protein function and structure, and nanomedicine.

The center will accelerate the translation of basic research outcomes into clinical applications, achieve industrialization, and drive the comprehensive enhancement of cancer prevention and control capabilities through scientific innovation.

The center’s members come from Tsinghua University’s School of Medicine, School of Pharmacy, School of Life Sciences, Department of Chemistry, and Department of Chemical Engineering, totaling 53 group leader.